Synergistic Antitumor Effects of Combined Treatment with HSP90 Inhibitor and PI3K/mTOR Dual Inhibitor in Cisplatin-Resistant Human Bladder Cancer Cells

PURPOSE: The current study aimed to investigate the synergistic antitumor effect of combined treatment with 17-DMAG (HSP90 inhibitor) and NVP-BEZ235 (PI3K/mTOR dual inhibitor) on cisplatin-resistant human bladder cancer cells. MATERIALS AND METHODS: Human bladder cancer cells exhibiting cisplatin re...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyung Joon, Gong, Mi Kyung, Yoon, Cheol Yong, Kang, Jaeku, Yun, Mijin, Cho, Nam Hoon, Rha, Sun Young, Choi, Young Deuk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329736/
https://www.ncbi.nlm.nih.gov/pubmed/32608202
http://dx.doi.org/10.3349/ymj.2020.61.7.587

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329736/
https://www.ncbi.nlm.nih.gov/pubmed/32608202
http://dx.doi.org/10.3349/ymj.2020.61.7.587

Ejemplares similares